REIT - Healthcare Facilities
Compare Stocks
5 / 10Stock Comparison
AHR vs VTR vs WELL vs HR vs OHI
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Healthcare Facilities
REIT - Healthcare Facilities
REIT - Healthcare Facilities
REIT - Healthcare Facilities
AHR vs VTR vs WELL vs HR vs OHI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | REIT - Healthcare Facilities | REIT - Healthcare Facilities | REIT - Healthcare Facilities | REIT - Healthcare Facilities | REIT - Healthcare Facilities |
| Market Cap | $9.92B | $41.50B | $150.37B | $7.03B | $14.05B |
| Revenue (TTM) | $652.49B | $6.13B | $11.63B | $1.15B | $1.24B |
| Net Income (TTM) | $23.79B | $260M | $1.43B | $-201M | $632M |
| Gross Margin | 97.8% | -4.3% | 39.1% | -9.7% | 85.5% |
| Operating Margin | 21.3% | 13.4% | 4.4% | 19.5% | 64.3% |
| Forward P/E | 68.8x | 119.0x | 79.6x | — | 23.9x |
| Total Debt | $1.59B | $13.22B | $21.38B | $4.15B | $4.26B |
| Cash & Equiv. | $115M | $741M | $5.03B | $26M | $27M |
AHR vs VTR vs WELL vs HR vs OHI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Feb 24 | May 26 | Return |
|---|---|---|---|
| American Healthcare… (AHR) | 100 | 378.3 | +278.3% |
| Ventas, Inc. (VTR) | 100 | 206.4 | +106.4% |
| Welltower Inc. (WELL) | 100 | 232.9 | +132.9% |
| Healthcare Realty T… (HR) | 100 | 146.2 | +46.2% |
| Omega Healthcare In… (OHI) | 100 | 151.6 | +51.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: AHR vs VTR vs WELL vs HR vs OHI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
AHR ranks third and is worth considering specifically for long-term compounding.
- 308.2% 10Y total return vs WELL's 225.2%
- +63.6% vs VTR's +36.1%
VTR is the clearest fit if your priority is growth exposure.
- Rev growth 18.5%, EPS growth 184.2%, 3Y rev CAGR 12.2%
WELL is the #2 pick in this set and the best alternative if sleep-well-at-night and defensive is your priority.
- Lower volatility, beta 0.15, Low D/E 49.5%, current ratio 5.34x
- Beta 0.15, yield 1.3%, current ratio 5.34x
- 35.8% FFO/revenue growth vs HR's -6.9%
- Beta 0.15 vs AHR's 0.24
HR is the clearest fit if your priority is income & stability.
- Dividend streak 0 yrs, beta 0.19, yield 5.5%
- 5.5% yield, vs WELL's 1.3%
OHI carries the broadest edge in this set and is the clearest fit for valuation efficiency.
- PEG 1.03 vs AHR's 1.03
- Better valuation composite
- 51.0% margin vs HR's -17.5%
- 6.1% ROA vs HR's -2.1%, ROIC 6.0% vs 0.7%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 35.8% FFO/revenue growth vs HR's -6.9% | |
| Value | Better valuation composite | |
| Quality / Margins | 51.0% margin vs HR's -17.5% | |
| Stability / Safety | Beta 0.15 vs AHR's 0.24 | |
| Dividends | 5.5% yield, vs WELL's 1.3% | |
| Momentum (1Y) | +63.6% vs VTR's +36.1% | |
| Efficiency (ROA) | 6.1% ROA vs HR's -2.1%, ROIC 6.0% vs 0.7% |
AHR vs VTR vs WELL vs HR vs OHI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
AHR vs VTR vs WELL vs HR vs OHI — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
OHI leads in 1 of 6 categories
AHR leads 1 • VTR leads 0 • WELL leads 0 • HR leads 0 • 4 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — AHR and OHI each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
AHR is the larger business by revenue, generating $652.5B annually — 567.8x HR's $1.1B. OHI is the more profitable business, keeping 51.0% of every revenue dollar as net income compared to HR's -17.5%. On growth, AHR holds the edge at +1202.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $652.5B | $6.1B | $11.6B | $1.1B | $1.2B |
| EBITDAEarnings before interest/tax | $139.0B | $2.3B | $2.8B | $767M | $1.1B |
| Net IncomeAfter-tax profit | $23.8B | $260M | $1.4B | -$201M | $632M |
| Free Cash FlowCash after capex | $267M | $1.4B | $2.5B | $201M | $912M |
| Gross MarginGross profit ÷ Revenue | +97.8% | -4.3% | +39.1% | -9.7% | +85.5% |
| Operating MarginEBIT ÷ Revenue | +21.3% | +13.4% | +4.4% | +19.5% | +64.3% |
| Net MarginNet income ÷ Revenue | +3.6% | +4.2% | +12.3% | -17.5% | +51.0% |
| FCF MarginFCF ÷ Revenue | +0.0% | +22.4% | +21.9% | +17.5% | +73.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +1202.8% | +22.0% | +40.3% | -10.5% | +16.7% |
| EPS Growth (YoY)Latest quarter vs prior year | +4.0% | 0.0% | +22.5% | +99.8% | +42.4% |
Valuation Metrics
Evenly matched — HR and OHI each lead in 3 of 7 comparable metrics.
Valuation Metrics
At 24.3x trailing earnings, OHI trades at a 85% valuation discount to VTR's 161.6x P/E. Adjusting for growth (PEG ratio), OHI offers better value at 1.04x vs AHR's 1.85x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $9.9B | $41.5B | $150.4B | $7.0B | $14.1B |
| Enterprise ValueMkt cap + debt − cash | $11.4B | $54.0B | $166.7B | $11.2B | $18.3B |
| Trailing P/EPrice ÷ TTM EPS | 123.12x | 161.64x | 154.41x | -28.38x | 24.32x |
| Forward P/EPrice ÷ next-FY EPS est. | 68.78x | 119.03x | 79.65x | — | 23.93x |
| PEG RatioP/E ÷ EPS growth rate | 1.85x | — | — | — | 1.04x |
| EV / EBITDAEnterprise value multiple | 32.06x | 24.47x | 66.86x | 16.92x | 17.01x |
| Price / SalesMarket cap ÷ Revenue | 4.39x | 7.11x | 14.10x | 5.95x | 11.73x |
| Price / BookPrice ÷ Book value/share | 2.57x | 3.21x | 3.38x | 1.51x | 2.69x |
| Price / FCFMarket cap ÷ FCF | 59.81x | 31.52x | 52.80x | 55.37x | 16.00x |
Profitability & Efficiency
OHI leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
OHI delivers a 11.9% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $-4 for HR. AHR carries lower financial leverage with a 0.47x debt-to-equity ratio, signaling a more conservative balance sheet compared to VTR's 1.05x. On the Piotroski fundamental quality scale (0–9), WELL scores 7/9 vs AHR's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +2.7% | +2.1% | +3.5% | -4.3% | +11.9% |
| ROA (TTM)Return on assets | +1.7% | +1.0% | +2.3% | -2.1% | +6.1% |
| ROICReturn on invested capital | +2.8% | +2.5% | +0.5% | +0.7% | +6.0% |
| ROCEReturn on capital employed | +3.4% | +3.2% | +0.6% | +1.0% | +7.9% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 | 7 | 7 | 6 |
| Debt / EquityFinancial leverage | 0.47x | 1.05x | 0.49x | 0.89x | 0.78x |
| Net DebtTotal debt minus cash | $1.5B | $12.5B | $16.3B | $4.1B | $4.2B |
| Cash & Equiv.Liquid assets | $115M | $741M | $5.0B | $26M | $27M |
| Total DebtShort + long-term debt | $1.6B | $13.2B | $21.4B | $4.1B | $4.3B |
| Interest CoverageEBIT ÷ Interest expense | 1.57x | 1.40x | 0.26x | -0.21x | 3.83x |
Total Returns (Dividends Reinvested)
AHR leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in AHR five years ago would be worth $40,817 today (with dividends reinvested), compared to $10,187 for HR. Over the past 12 months, AHR leads with a +63.6% total return vs VTR's +36.1%. The 3-year compound annual growth rate (CAGR) favors AHR at 59.8% vs HR's 5.7% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +10.0% | +13.5% | +15.2% | +20.3% | +9.0% |
| 1-Year ReturnPast 12 months | +63.6% | +36.1% | +46.7% | +38.3% | +40.3% |
| 3-Year ReturnCumulative with dividends | +308.2% | +95.8% | +191.6% | +18.2% | +89.9% |
| 5-Year ReturnCumulative with dividends | +308.2% | +75.6% | +206.1% | +1.9% | +66.3% |
| 10-Year ReturnCumulative with dividends | +308.2% | +66.1% | +225.2% | +40.1% | +113.0% |
| CAGR (3Y)Annualised 3-year return | +59.8% | +25.1% | +42.9% | +5.7% | +23.8% |
Risk & Volatility
Evenly matched — VTR and OHI each lead in 1 of 2 comparable metrics.
Risk & Volatility
OHI is the less volatile stock with a -0.09 beta — it tends to amplify market swings less than AHR's 0.24 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. VTR currently trades 98.6% from its 52-week high vs AHR's 94.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.24x | -0.01x | 0.15x | 0.19x | -0.09x |
| 52-Week HighHighest price in past year | $54.67 | $88.50 | $219.59 | $20.46 | $49.14 |
| 52-Week LowLowest price in past year | $32.15 | $61.76 | $142.65 | $14.09 | $35.09 |
| % of 52W HighCurrent price vs 52-week peak | +94.6% | +98.6% | +97.7% | +98.5% | +96.0% |
| RSI (14)Momentum oscillator 0–100 | 49.2 | 55.8 | 54.5 | 71.8 | 49.2 |
| Avg Volume (50D)Average daily shares traded | 2.4M | 3.5M | 2.6M | 3.6M | 1.9M |
Analyst Outlook
Evenly matched — WELL and HR each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: AHR as "Buy", VTR as "Buy", WELL as "Buy", HR as "Hold", OHI as "Hold". Consensus price targets imply 9.7% upside for AHR (target: $57) vs 0.5% for HR (target: $20). For income investors, HR offers the higher dividend yield at 5.49% vs WELL's 1.29%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Hold | Hold |
| Price TargetConsensus 12-month target | $56.75 | $93.91 | $233.25 | $20.25 | $49.63 |
| # AnalystsCovering analysts | 11 | 32 | 34 | 29 | 28 |
| Dividend YieldAnnual dividend ÷ price | +1.9% | +2.1% | +1.3% | +5.5% | +5.3% |
| Dividend StreakConsecutive years of raises | 1 | 1 | 2 | 0 | 0 |
| Dividend / ShareAnnual DPS | $0.98 | $1.86 | $2.76 | $1.11 | $2.51 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.0% | 0.0% | 0.0% | +0.1% | 0.0% |
OHI leads in 1 of 6 categories (Profitability & Efficiency). AHR leads in 1 (Total Returns). 4 tied.
AHR vs VTR vs WELL vs HR vs OHI: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is AHR or VTR or WELL or HR or OHI a better buy right now?
For growth investors, Welltower Inc.
(WELL) is the stronger pick with 35. 8% revenue growth year-over-year, versus -6. 9% for Healthcare Realty Trust Incorporated (HR). Omega Healthcare Investors, Inc. (OHI) offers the better valuation at 24. 3x trailing P/E (23. 9x forward), making it the more compelling value choice. Analysts rate American Healthcare REIT, Inc. (AHR) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — AHR or VTR or WELL or HR or OHI?
On trailing P/E, Omega Healthcare Investors, Inc.
(OHI) is the cheapest at 24. 3x versus Ventas, Inc. at 161. 6x. On forward P/E, Omega Healthcare Investors, Inc. is actually cheaper at 23. 9x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Omega Healthcare Investors, Inc. wins at 1. 03x versus American Healthcare REIT, Inc. 's 1. 03x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — AHR or VTR or WELL or HR or OHI?
Over the past 5 years, American Healthcare REIT, Inc.
(AHR) delivered a total return of +308. 2%, compared to +1. 9% for Healthcare Realty Trust Incorporated (HR). Over 10 years, the gap is even starker: AHR returned +308. 2% versus HR's +40. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — AHR or VTR or WELL or HR or OHI?
By beta (market sensitivity over 5 years), Omega Healthcare Investors, Inc.
(OHI) is the lower-risk stock at -0. 09β versus American Healthcare REIT, Inc. 's 0. 24β — meaning AHR is approximately -355% more volatile than OHI relative to the S&P 500. On balance sheet safety, American Healthcare REIT, Inc. (AHR) carries a lower debt/equity ratio of 47% versus 105% for Ventas, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — AHR or VTR or WELL or HR or OHI?
By revenue growth (latest reported year), Welltower Inc.
(WELL) is pulling ahead at 35. 8% versus -6. 9% for Healthcare Realty Trust Incorporated (HR). On earnings-per-share growth, the picture is similar: American Healthcare REIT, Inc. grew EPS 244. 8% year-over-year, compared to -11. 5% for Welltower Inc.. Over a 3-year CAGR, WELL leads at 22. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — AHR or VTR or WELL or HR or OHI?
Omega Healthcare Investors, Inc.
(OHI) is the more profitable company, earning 49. 3% net margin versus -20. 8% for Healthcare Realty Trust Incorporated — meaning it keeps 49. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: OHI leads at 62. 6% versus 3. 3% for WELL. At the gross margin level — before operating expenses — OHI leads at 44. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is AHR or VTR or WELL or HR or OHI more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Omega Healthcare Investors, Inc. (OHI) is the more undervalued stock at a PEG of 1. 03x versus American Healthcare REIT, Inc. 's 1. 03x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Omega Healthcare Investors, Inc. (OHI) trades at 23. 9x forward P/E versus 119. 0x for Ventas, Inc. — 95. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AHR: 9. 7% to $56. 75.
08Which pays a better dividend — AHR or VTR or WELL or HR or OHI?
All stocks in this comparison pay dividends.
Healthcare Realty Trust Incorporated (HR) offers the highest yield at 5. 5%, versus 1. 3% for Welltower Inc. (WELL).
09Is AHR or VTR or WELL or HR or OHI better for a retirement portfolio?
For long-horizon retirement investors, Omega Healthcare Investors, Inc.
(OHI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 09), 5. 3% yield, +113. 0% 10Y return). Both have compounded well over 10 years (OHI: +113. 0%, HR: +40. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between AHR and VTR and WELL and HR and OHI?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: AHR is a small-cap quality compounder stock; VTR is a mid-cap high-growth stock; WELL is a mid-cap high-growth stock; HR is a small-cap income-oriented stock; OHI is a mid-cap income-oriented stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.